Plasminogen activation at the cell surface

Current Topics in Developmental Biology

Volumn 54, Issue , 2003, Pages 263-312

  Ellis, Vincent ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; SERINE PROTEINASE;

ANIMAL; ARTERIOSCLEROSIS; BINDING SITE; ENZYME ACTIVE SITE; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; BINDING SITES; CATALYTIC DOMAIN; HUMANS; MEMBRANE PROTEINS; NEOPLASMS; PLASMINOGEN; PLASMINOGEN ACTIVATORS; PROTEIN STRUCTURE, TERTIARY; SERINE ENDOPEPTIDASES;

EID: 0642308407     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0070-2153(03)54012-1     Document Type: Review

References (217)

1. J.A Aguirre Ghiso Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo Oncogene 21 2002 2513 2524
2. J.A Aguirre Ghiso K Kovalski L Ossowski Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling J. Cell Biol. 147 1999 89 104
3. S.S An C Carreno D.N Marti J Schaller F Albericio M Llinas Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles Protein Sci. 7 1998 1960 1969
4. N.M Andronicos M Ranson The topology of plasminogen binding and activation on the surface of human breast cancer cells Br. J. Cancer 85 2001 909 916
5. K Bajou V Masson R.D Gerard P.M Schmitt V Albert M Praus L.R Lund T.L Frandsen N Brunner K Dano N.E Fusenig U Weidle G Carmeliet D Loskutoff D Collen P Carmeliet J.M Foidart A Noel The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin Implications for antiangiogenic strategies J. Cell Biol. 152 2001 777 784
6. K Bajou A Noel R.D Gerard V Masson N Brunner C Holst-Hansen M Skobe N.E Fusenig P Carmeliet D Collen J.M Foidart Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization Nat. Med. 4 1998 923 928
7. J.A Bezerra T.H Bugge H Melin-Aldana G Sabla K.W Kombrinck D.P Witte J.L Degen Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver Proc. Natl. Acad. Sci. USA 96 1999 15143 15148
8. W Bode The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. II. The binding of the pancreatic trypsin inhibitor and of isoleucine-valine and of sequentially related peptides to trypsinogen and to p-guanidinobenzoate-trypsinogen J. Mol. Biol. 127 1979 357 374
9. W Bode M Renatus Tissue-type plasminogen activator: variants and crystal/solution structures demarcate structural determinants of function Curr. Opin. Struct. Biol. 7 1997 865 872
10. P Bork A Bairoch Extracellular protein modules: A proposed nomenclature Trends Biochem. Sci. 20 1995 poster C02
11. T.H Bugge M.J Flick M.J Danton C.C Daugherty J Rømer K Danø P Carmeliet D Collen J.L Degen Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator Proc. Natl. Acad. Sci. USA 93 1996 5899 5904
12. T.H Bugge K.W Kombrinck M.J Flick C.C Daugherty M.J.S Danton J.L Degen Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency Cell 87 1996 709 719
13. T.H Bugge K.W Kombrinck Q Xiao K Holmback C.C Daugherty D.P Witte J.L nd Degen Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice Blood 90 1997 4522 4531
14. T.H Bugge L.R Lund K.K Kombrinck B.S Nielsen K Holmback A.F Drew M.J Flick D.P Witte K Dano J.L Degen Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice Oncogene 16 1998 3097 3104
15. T.H Bugge T.T Suh M.J Flick C.C Daugherty J Rømer H Solberg V Ellis K Danø J.L Degen The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility J. Biol. Chem. 270 1995 16886 16894
16. N Busso S.K Masur D Lazega S Waxman L Ossowski Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in uman epithelial cells J. Cell Biol. 126 1994 259 270
17. P Carmeliet L Moons M Dewerchin S Rosenberg J.-M Herbert F Lupu D Collen Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice J. Cell Biol. 140 1998 233 245
18. P Carmeliet L Moons J.-M Herbert J Crawley F Lupu H.R Lijnen D Collen Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice Circ. Res. 81 1997 829 839
19. P Carmeliet L Moons R Lijnen M Baes V Lemaîytre P Tipping A Drew Y Eeckhout S Shapiro F Lupu D Collen Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation Nat. Genet. 17 1997 439 444
20. P Carmeliet L Moons R Lijnen S Janssens F Lupu D Collen R.D Gerard Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation—A gene targeting and gene transfer study in mice Circulation 96 1997 3180 3191
21. M.V Carriero S Del Vecchio M Capozzoli P Franco L Fontana A Zannetti G Botti G D'Aiuto M Salvatore M.P Stoppelli Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer Cancer Res. 59 1999 5307 5314
22. F.J Castellino Plasmin A.J Barrett N.D Rawlings J.F Woessner Handbook of Proteolytic Enzymes 1998 Academic Press London 190 199
23. G.M Cesarman C.A Guevara K.A Hajjar An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation J. Biol. Chem. 269 1994 21198 21203
24. Z.L Chen S Strickland Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin Cell 91 1997 917 925
25. A.W Clowes M.M Clowes Y.P.T Au M.A Reidy D Belin Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery Circ. Res. 67 1990 61 67
26. 2-Macroglobulin receptor/LDL receptor-related protein(LRP)-dependent internalization of the urokinase receptor J. Cell Biol. 131 1995 1609 1622
27. C.W Crowley R.L Cohen B.K Lucas G Liu M.A Shuman A.D Levinson Prevention of metastasis by inhibition of the urokinase receptor Proc. Natl. Acad. Sci. USA 90 1993 5021 5025
28. M.V Cubellis T.C Wun F Blasi Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1 EMBO J. 9 1990 1079 1085
29. D D'Orazio D Besser R Marksitzer C Kunz D.A Hume B Kiefer Y Nagamine Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2 Gene 201 1997 179 187
30. K Danø P.A Andreasen J Grøndahl-Hansen P Kristensen L.S Nielsen L Skriver Plasminogen activators, tissue degradation and cancer Adv. Cancer Res. 44 1985 139 266
31. K Danø J Rømer B.S Nielsen S Bjorn C Pyke J Rygaard L.R Lund Cancer invasion and tissue remodeling-cooperation of protease systems and cell types APMIS 107 1999 120 127
32. B.J Davies B.S Pickard M Steel R.G Morris R Lathe Serine proteases in rodent hippocampus J. Biol. Chem. 273 1998 23004 23011
33. R.L Davis A.E Shrimpton P.D Holohan C Bradshaw D Feiglin G.H Collins P Sonderegger J Kinter L.M Becker F Lacbawan D Krasnewich M Muenke D.A Lawrence M.S Yerby C.M Shaw B Gooptu P.R Elliott J.T Finch R.W Carrell D.A Lomas Familial dementia caused by polymerization of mutant neuroserpin Nature 401 1999 376 379
34. G Deng S.A Curriden S.J Wang S Rosenberg D.J Loskutoff Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J. Cell Biol. 134 1996 1563 1571
35. L.E Donate E Gherardi N Srinivasan R Sowdhamini S Aparicio T.L Blundell Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP) Protein Sci. 3 1994 2378 2394
36. M.J Duffy Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers Biochem. Soc. Trans. 30 2002 207 210
37. I Dumler A Weis O.A Mayboroda C Maasch U Jerke H Haller D.C Gulba The Jak/Stat pathway and urokinase receptor signaling inhuman aortic vascular smooth muscle cells J. Biol. Chem. 273 1998 315 321
38. H.F Dvorak Tumors: wounds that do not heal Similarities between tumor stroma generation and wound healing N. Engl. J. Med. 315 1986 1650 1659
39. V Ellis Functional analysis of the cellular receptor for urokinase in plasminogen activation J. Biol. Chem. 271 1996 14779 14784
40. V Ellis K Danø Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation A mechanistic model for receptor-mediated plasminogen activation J. Biol. Chem. 268 1993 4806 4813
41. V Ellis K Danø Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin Biochem. J. 296 1993 505 510
42. V Ellis G Murphy Cellular strategies for proteolytic targeting during migration and invasion FEBS Lett. 506 2001 1 5
43. V Ellis S.A Whawell Vascular smooth muscle cells potentiate plasmin generation by both urokinase and tissue plasminogen activator dependent mechanisms: Evidence for a specific tPA receptor on these cells Blood 90 1997 2312 2322
44. V Ellis N Behrendt K Danø Plasminogen activation by receptor-bound urokinase A kinetic study with both cell-associated and isolated receptor J. Biol. Chem. 266 1991 12752 12758
45. V Ellis M Daniels R Misra D.R Brown Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner Biochemistry 41 2002 6891 6896
46. V Ellis M.F Scully V.V Kakkar Plasminogen activation by single-chain urokinase in functional isolation A kinetic study J. Biol. Chem. 262 1987 14998 15003
47. V Ellis M.F Scully V.V Kakkar Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes J. Biol. Chem. 264 1989 2185 2188
48. V Ellis S.A Whawell F Werner J.J Deadman Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen Biochemistry 38 1999 651 659
49. V Ellis T.-C Wun N Behrendt E Rønne K Danø Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors J. Biol. Chem. 265 1990 9904 9908
50. A Estreicher J Muhlhauser J.L Carpentier L Orci J.D Vassalli The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes J. Cell Biol. 111 1990 783 792
51. D.J Falcone W Borth K.M Khan K.A Hajjar Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II Blood 97 2001 777 784
52. F Fazioli M Resnati N Sidenius Y Higashimoto E Appella F Blasi A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity EMBO J. 16 1997 7279 7286
53. P Feng M Ohlsson T Ny The structure of the TATA-less rat tissue-type plasminogen activator gene Species-specific sequence divergences in the promoter predict differences in regulation of gene expression J. Biol. Chem. 265 1990 2022 2027
54. M.B Fischer C Roeckl P Parizek H.P Schwarz A Aguzzi Binding of disease-associated prion protein to plasminogen Nature 408 2000 479 483
55. G.C Friedman N.W Seeds Tissue plasminogen activator expression in the embryonic nervous system Dev. Brain Res. 81 1994 41 49
56. H Gårdsvoll K Dano M Ploug Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis J. Biol. Chem. 274 1999 37995 38003
57. D.J Grainger H.L Kirschenlohr J.C Metcalfe P.L Weissberg D.P Wade R.M Lawn Proliferation of human smooth muscle cells promoted by lipoprotein(a) Science 260 1993 1655 1658
58. D.J Grainger L Wakefield H.W Bethell R.W Farndale J.C Metcalfe Release and activation of platelet latent TGF-β in blood clots during dissolution with plasmin Nature Med. 1 1995 932 937
59. A Gualandris T.E Jones S Strickland S.E Tsirka Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator J. Neurosci. 16 1996 2220 2225
60. W.A Gunzler G.J Steffens F Otting G Buse L Flohe Structural relationship between human high and low molecular mass urokinase Hoppe Seylers Z. Physiol. Chem. 363 1982 133 141
61. M.R Gyetko R.G Sitrin J.A Fuller R.F Todd 3rd H Petty T.J Standiford Function of the urokinase receptor (CD87) in neutrophil chemotaxis J. Leukocyte Biol. 58 1995 533 538
62. K.A Hajjar C.A Guevara E Lev K Dowling J Chacko Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface Essential role of endonexin repeat 2 J. Biol. Chem. 271 1996 21652 21659
63. K.A Hajjar A.T Jacovina J Chacko An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II J. Biol. Chem. 269 1994 21191 21197
64. S.W Hall J.E Humphries S.L Gonias Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin J. Biol. Chem. 266 1991 12329 12336
65. N Hattori J.L Degen T.H Sisson H Liu B.B Moore R.G Pandrangi R.H Simon A.F Drew Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice J. Clin. Invest. 106 2000 1341 1350
66. S.B Hawley M.A Green L.A Miles Discriminating between cell surface and intracellular plasminogen-binding proteins: heterogeneity in profibrinolytic plasminogen-binding proteins on monocytoid cells Thromb. Haemost. 84 2000 882 890
67. S.B Hawley T Tamura L.A Miles Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a J. Biol. Chem. 276 2001 179 186
68. C He S.M Wilhelm A.P Pentland B.L Marner G.A Grant A.Z Eisen G.I Goldberg Tissue cooperation in a proteolytic cascade activating human interstitial collagenase Proc. Natl. Acad. Sci. USA 86 1989 2632 2636
69. T.A Hembrough J Vasudevan M.M Allietta W.F Glass 2nd S.L Gonias A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines J. Cell Sci. 108 1995 1071 1082
70. B.R Henderson M.J Sleigh TATA box-independent transcription of the human tissue plasminogen activator gene initiates within a sequence conserved in related genes FEBS Lett. 309 1992 130 134
71. S Heymans A Luttun D Nuyens G Theilmeier E Creemers L Moons G.D Dyspersin J.P Cleutjens M Shipley A Angellilo M Levi O Nube A Baker E Keshet F Lupu J.M Herbert J.F Smits S.D Shapiro M Baes M Borgers D Collen M.J Daemen P Carmeliet Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure Nat. Med. 5 1999 1135 1142
72. A.A Higazi R.H Upson R.L Cohen J Manuppello J Bognacki J Henkin K.R McCrae M.Z Kounnas D.K Strickland K.T Preissner J Lawler D.B Cines Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins Blood 88 1996 542 551
73. N Hiraoka E Allen I.J Apel M.R Gyetko S.J Weiss Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins Cell 95 1998 365 377
74. M Holmberg G Leonardsson T Ny The species-specific differences in the cAMP regulation of the tissue-type plasminogen activator gene between rat, mouse and human is caused by a one-nucleotide substitution in the cAMP-responsive element of the promoters Eur. J. Biochem. 231 1995 466 474
75. J.D Hooper J.A Clements J.P Quigley T.M Antalis Type II transmembrane serine proteases Insights into an emerging class of cell surface proteolytic enzymes J. Biol. Chem. 276 2001 857 860
76. G Høyer-Hansen N Behrendt M Ploug K Danø K.T Preissner The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction FEBS Lett. 420 1997 79 85
77. G Høyer-Hansen E Rønne H Solberg N Behrendt M Ploug L.R Lund V Ellis K Danø Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain J. Biol. Chem. 267 1992 18224 18229
78. M Hoylaerts D.C Rijken H.R Lijnen D Collen Kinetics of the activation of plasminogen by human tissue plasminogen activator Role of fibrin J. Biol. Chem. 257 1982 2912 2919
79. Y.Y Huang M.E Bach H.P Lipp M Zhuo D.P Wolfer R.D Hawkins L Schoonjans E.R Kandel J.M Godfraind R Mulligan D Collen P Carmeliet Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways Proc. Natl. Acad. Sci. USA 93 1996 8699 8704
80. J Huarte D Belin A Vassalli S Strickland J.D Vassalli Meiotic maturation of mouse oocytes triggers the translation and polyadenylation of dormant tissue-type plasminogen activator mRNA Genes Dev. 1 1987 1201 1211
81. D Huber E.M Cramer J.E Kaufmann P Meda J.M Masse E.K Kruithof U.M Vischer Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo Blood 99 2002 3637 3645
82. R Huber W Bode Structural basis of the activation and action of trypsin Acc. Chem. Research 11 1978 114 122
83. A Ichinose K Fujikawa T Suyama The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin J. Biol. Chem. 261 1986 3486 3489
84. J.P Irigoyen D Besser Y Nagamine Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/extracellular signal-regulated kinase (ERK) signaling pathway J. Biol. Chem. 272 1997 1904 1909
85. J.P Irigoyen P Munoz-Canoves L Montero M Koziczak Y Nagamine The plasminogen activator system: biology and regulation Cell Mol. Life Sci. 56 1999 104 132
86. A.T Jacovina F Zhong E Khazanova E Lev A.B Deora K.A Hajjar Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation J. Biol. Chem. 276 2001 49350 49358
87. F.J Joubert E.B Dowdle The primary structure of the inhibitor of tissue plasminogen activator found in the seeds of Erythrina caffra Thromb. Haemost. 57 1987 356 360
88. G Kassam K.S Choi J Ghuman H.M Kang S.L Fitzpatrick T Zackson S Zackson M Toba A Shinomiya D.M Waisman The role of annexin II tetramer in the activation of plasminogen J. Biol. Chem. 273 1998 4790 4799
89. G Kassam B.H Le K.S Choi H.M Kang S.L Fitzpatrick P Louie D.M Waisman The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation Biochemistry 37 1998 16958 16966
90. Y Kawai Y Matsumoto K Watanabe H Yamamoto K Satoh M Murata M Handa Y Ikeda Hemodynamic forces modulate the effects of cytokines on fibrinolytic activity of endothelial cells Blood 87 1996 2314 2321
91. A.L Kindzelskii M.M Eszes R.F Todd H.R Petty Proximity oscillations of complement type 4 (alphaX beta2) and urokinase receptors on migrating neutrophils Biophys. J. 73 1997 1777 1784
92. A.L Kindzelskii Z.O Laska R.F Todd H.R Petty Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2 CD11b/CD18) during neutrophil polarization J. Immunol. 156 1996 297 309
93. I.B Kingston M.J Castro S Anderson In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues Nat. Med. 1 1995 138 142
94. L Kjøller A Hall Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin J. Cell Biol. 152 2001 1145 1158
95. H Kobayashi M Schmitt L Goretzki N Chucholowski J Calvete M Kramer W.A Gunzler F Janicke H Graeff Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA) J. Biol. Chem. 266 1991 5147 5152
96. Y.H Kook J Adamski A Zelent L Ossowski The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy EMBO J. 13 1994 3983 3991
97. M.M Krem T Rose E Di Cera Sequence determinants of function and evolution in serine proteases Trends Cardiovasc. Med. 10 2000 171 176
98. P Kristensen C Pyke L.R Lund P.A Andreasen K Dano Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma Histochemistry 93 1990 559 566
99. M Lansink T Kooistra Stimulation of tissue-type plasminogen activator expression by retinoic acid in human endothelial cells requires retinoic acid receptor beta 2 induction Blood 88 1996 531 541
100. M.D Ledesma J.S Da Silva K Crassaerts A Delacourte B De Strooper C.G Dotti Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains EMBO Rep. 1 2000 530 535
101. R Lee P Kermani K.K Teng B.L Hempstead Regulation of cell survival by secreted proneurotrophins Science 294 2001 1945 1948
102. S.W Lee V Ellis D.A Dichek Characterization of plasminogen activation by glycosylphosphatidylinositol-anchored urokinase J. Biol. Chem. 269 1994 2411 2418
103. H.R Lijnen Extracellular proteolysis in the development and progression of atherosclerosis Biochem. Soc. Trans. 30 2002 163 167
104. L.A Liotta R.H Goldfarb R Brundage G.P Siegal V Terranova S Garbisa Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane Cancer Res. 41 1981 4629 4636
105. K List O.N Jensen T.H Bugge L.R Lund M Ploug K Dano N Behrendt Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice Biochemistry 39 2000 508 515
106. S Liu H Aaronson D.J Mitola S.H Leppla T.H Bugge Potent anti-tumor activity of a urokinase-activated engineered anthrax toxin Proc. Natl. Acad. Sci. USA. 2002 In Press
107. S Liu T.H Bugge S.H Leppla Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin J. Biol. Chem. 276 2001 17976 17984
108. C Longstaff R.E Merton P Fabregas J Felez Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87) Blood 93 1999 3839 3846
109. M.P Look W.L van Putten M.J Duffy N Harbeck I.J Christensen C Thomssen R Kates F Spyratos M Ferno S Eppenberger-Castori C.G Sweep K Ulm J.P Peyrat P.M Martin H Magdelenat N Brunner C Duggan B.W Lisboa P.O Bendahl V Quillien A Daver G Ricolleau M.E Meijer-van Gelder P Manders W.E Fiets M.A Blankenstein P Broet S Romain G Daxenbichler G Windbichler T Cufer S Borstnar W Kueng L.V Beex J.G Klijn N O'Higgins U Eppenberger F Janicke M Schmitt J.A Foekens Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients J. Natl. Cancer Inst. 94 2002 116 128
110. D.J Loskutoff J.P Quigley PAI-1, fibrosis, and the elusive provisional fibrin matrix J. Clin. Invest. 106 2000 1441 1443
111. L.R Lund V Ellis E Rønne C Pyke K Danø Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549 Biochem. J. 310 1995 345 352
112. L.R Lund J Rømer T.H Bugge B.S Nielsen T.L Frandsen J.L Degen R.W Stephens K Danø Functional overlap between two classes of matrix-degrading proteases in wound healing EMBO J. 18 1999 4645 4656
113. L.R Lund J Rømer E Rønne V Ellis F Blasi K Danø Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells EMBO J. 10 1991 3399 3407
114. F Lupu D.A Heim F Bachmann M Hurni V.V Kakkar E.K.O Kruithof Plasminogen activator expression in human atherosclerotic lesions Arterioscler. Thromb. Vasc. Biol. 15 1995 1444 1455
115. A Luttun F Lupu E Storkebaum M.F Hoylaerts L Moons J Crawley F Bono A.R Poole P Tipping J.M Herbert D Collen P Carmeliet Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice Arterioscler. Thromb. Vasc. Biol. 22 2002 499 505
116. J.R MacDougall L.M Matrisian Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis Cancer Metastasis Rev. 14 1995 351 362
117. R Madani S Hulo N Toni H Madani T Steimer D Muller J.D Vassalli Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice EMBO J. 18 1999 3007 3012
118. V Magdolen M Burgle N.A de Prada N Schmiedeberg C Riemer F Schroeck J Kellermann K Degitz O.G Wilhelm M Schmitt H Kessler Cyclo19,31[D-Cys19]-uPA19- 31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87) Biol. Chem. 382 2001 1197 1205
119. J Mai R.L Finley Jr. D.M Waisman B.F Sloane Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells J. Biol. Chem. 275 2000 12806 12812
120. S.J Mandriota G Seghezzi J.D Vassalli N Ferrara S Wasi R Mazzieri P Mignatti M.S Pepper Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells J. Biol. Chem. 270 1995 9709 9716
121. W.F Mangel B.H Lin V Ramakrishnan Characterization of an extremely large, ligand-induced conformational change in plasminogen Science 248 1990 69 73
122. W.M Mars R Zarnegar G.K Michalopoulos Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA Am. J. Pathol. 143 1993 949 958
123. D.N Marti C.-K Hu S.S.A An P Von Haller J Schaller M Llinás Ligand preferences of kringle 2 and homologous domains of human plasminogen: Canvassing weak, intermediate, and high-affinity binding sites by 1 H-NMR Biochemistry 36 1997 11591 11604
124. Y Matsuoka Y Kitamura T Taniguchi Induction of plasminogen in rat hippocampal pyramidal neurons by kainic acid Neurosci. Lett. 252 1998 119 122
125. R Mazzieri L Masiero L Zanetta S Monea M Onisto S Garbisa P Mignatti Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants EMBO J. 16 1997 2319 2332
126. R.L Medcalf R.I Richards R.J Crawford J.A Hamilton Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids EMBO J. 5 1986 2217 2222
127. L.A Miles C.M Dahlberg E.G Levin E.F Plow Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells Biochemistry 28 1989 9337 9343
128. L.A Miles C.M Dahlberg J Plescia J Felez K Kato E.F Plow Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor Biochemistry 30 1991 1682 1691
129. H.Y Min L.V Doyle C.R Vitt C.L Zandonella J.R Stratton-Thomas M.A Shuman S Rosenberg Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice Cancer Res. 56 1996 2428 2433
130. G Murphy H Stanton S Cowell G Butler V Knauper S Atkinson J Gavrilovic Mechanisms for pro matrix metalloproteinase activation APMIS 107 1999 38 44
131. L Naldini L Tamagnone E Vigna M Sachs G Hartmann W Birchmeier Y Daikuhara H Tsubouchi F Blasi P.M Comoglio Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor EMBO J. 11 1992 4825 4833
132. R Nanbu P.A Menoud Y Nagamine Multiple instability-regulating sites in the 3 untranslated region of the urokinase-type plasminogen activator mRNA Mol. Cell Biol. 14 1994 4920 4928
133. C Nerlov D De Cesare F Pergola A Caracciolo F Blasi M Johnsen P Verde A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells EMBO J. 11 1992 4573 4582
134. D.H Nguyen I.M Hussaini S.L Gonias Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility J. Biol. Chem. 273 1998 8502 8507
135. O Nicole F Docagne C Ali I Margaill P Carmeliet E.T MacKenzie D Vivien A Buisson The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling Nat. Med. 7 2001 59 64
136. C.D Nobes A Hall Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia Cell 81 1995 53 62
137. A.R Nusrat H.A Chapman An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines J. Clin. Invest. 87 1991 1091 1097
138. A Nykjær M Conese E.I Christensen D Olson O Cremona J Gliemann F Blasi Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes EMBO J. 16 1997 2610 2620
139. A Nykjær C.M Petersen B Moller P.H Jensen S.K Moestrup T.L Holtet M Etzerodt H.C Thogersen M Munch P.A Andreasen J Gliemann Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes J. Biol. Chem. 267 1992 14543 14546
140. L.E Odekon F Blasi D.B Rifkin Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta J. Cell. Physiol. 158 1994 398 407
141. S.S Okada J.E Tomaszewski E.S Barnathan Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro Exp. Cell Res. 217 1995 180 187
142. Y Okumura Y Kamikubo S.A Curriden J Wang T Kiwada S Futaki K Kitagawa D.J Loskutoff Kinetic analysis of the interaction between vitronectin and the urokinase receptor J. Biol. Chem. 277 2002 9395 9404
143. T Osterwalder P Cinelli A Baici A Pennella S.R Krueger S.P Schrimpf M Meins P Sonderegger The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin J. Biol. Chem. 273 1998 2312 2321
144. N.F Paoni A.M Chow L.C Pena B.A Keyt M.J Zoller W.F Bennett Making tissue-type plasminogen activator more fibrin specific Protein Eng. 6 1993 529 534
145. R.J Parmer M Mahata S Mahata M.T Sebald D.T O'Connor L.A Miles Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway Catecholamine storage vesicles as a reservoir for the rapid release of t-PA J. Biol. Chem. 272 1997 1976 1982
146. L Patthy Genome evolution and the evolution of exon-shuffling-a review Gene 238 1999 103 114
147. D Pennica W.E Holmes W.J Kohr R.N Harkins G.A Vehar C.A Ward W.F Bennett E Yelverton P.H Seeburg H.L Heyneker D.V Goeddel D Collen Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli Nature 301 1983 214 221
148. L.C Petersen L.R Lund L.S Nielsen K Danø L Skriver One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity J. Biol. Chem. 263 1988 11189 11195
149. T Plesner M Ploug V Ellis E Rønne G Høyer-Hansen M Wittrup T.L Pedersen T Tscherning K Danø N.E Hansen The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils Blood 83 1994 808 815
150. M Ploug V Ellis Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom α-neurotoxins FEBS Lett. 349 1994 163 168 [Review]
151. M Ploug V Ellis K Danø Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate Evidence for a hydrophobic binding site exposed only on the intact receptor Biochemistry 33 1994 8991 8997
152. M Ploug S Ostergaard L.B Hansen A Holm K Dano Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist Evidence for a composite ligand-binding site and a short interdomain separation Biochemistry 37 1998 3612 3622
153. M Ploug H Rahbek-Nielsen V Ellis P Roepstorff K Danø Chemical modification of the urokinase-type plasminogen activator and its receptor using tetranitromethane Evidence for the involvement of specific tyrosine residues in both molecules during receptor-ligand interaction Biochemistry 34 1995 12524 12534
154. M Ploug E Rønne N Behrendt A.L Jensen F Blasi K Danø Cellular receptor for urokinase plasminogen activator Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol J. Biol. Chem. 266 1991 1926 1933
155. E.F Plow D.E Freaney J Plescia L.A Miles The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type J. Cell Biol. 103 1986 2411 2420
156. J Pollanen K Hedman L.S Nielsen K Dano A Vaheri Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts J. Cell Biol. 106 1988 87 95
157. S.B Prusiner Prions Proc. Natl. Acad. Sci. USA 95 1998 13363 13383
158. C Pyke P Kristensen E Ralfkiaer J Eriksen K Dano The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma Cancer Res. 51 1991 4067 4071
159. C Pyke P Kristensen E Ralfkiaer J Grøndahl-Hansen J Eriksen F Blasi K Danø Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas Am. J. Pathol. 138 1991 1059 1067
160. Z Qian M.E Gilbert M.A Colicos E.R Kandel D Kuhl Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation Nature 361 1993 453 457
161. M Renatus R.A Engh M.T Stubbs R Huber S Fischer U Kohnert W Bode Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA EMBO J. 16 1997 4797 4805
162. M Resnati M Guttinger S Valcamonica N Sidenius F Blasi F Fazioli Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect EMBO J. 15 1996 1572 1582
163. M Resnati I Pallavicini J.M Wang J Oppenheim C.N Serhan M Romano F Blasi The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R Proc. Natl. Acad. Sci. USA 99 2002 1359 1364
164. J Rømer T.H Bugge C Pyke L.R Lund M.J Flick J.L Degen K Danø Impaired wound healing in mice with a disrupted plasminogen gene Nat. Med. 2 1996 287 292
165. J Rømer L.R Lund J Eriksen C Pyke P Kristensen K Danø The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds J. Invest. Dermatol. 102 1994 519 522
166. M.E Russell T Quertermous P.J Declerck D Collen E Haber C.J Homcy Binding of tissue-type plasminogen activator with human endothelial cell monolayers Characterization of the high affinity interaction with plasminogen activator inhibitor-1 J. Biol. Chem. 265 1990 2569 2575
167. O Saksela D.B Rifkin Release of basic fibroblast growth factor-heparan sulphate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity J. Cell Biol. 110 1990 767 775
168. A.P Sappino R Madani J Huarte D Belin J.Z Kiss A Wohlwend J.D Vassalli Extracellular proteolysis in the adult murine brain J. Clin. Invest. 92 1993 679 685
169. M.A Schwartz Integrin signaling revisited Trends Cell Biol. 11 2001 466 470
170. N.W Seeds M.E Basham S.P Haffke Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene Proc. Natl. Acad. Sci. USA 96 1999 14118 14123
171. N.W Seeds B.L Williams P.C Bickford Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning Science 270 1995 1992 1994
172. D Seiffert G Ciambrone N.V Wagner B.R Binder D.J Loskutoff The somatomedin B domain of vitronectin Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor J. Biol. Chem. 269 1994 2659 2666
173. C.J Siao S.E Tsirka Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II J. Neurosci. 22 2002 3352 3358
174. G.A Silverman P.I Bird R.W Carrell F.C Church P.B Coughlin P.G Gettins J.A Irving D.A Lomas C.J Luke R.W Moyer P.A Pemberton E Remold-O'Donnell G.S Salvesen J Travis J.C Whisstock The serpins are an expanding superfamily of structurally similar but functionally diverse proteins Evolution, mechanism of inhibition, novel functions, and a revised nomenclature J. Biol. Chem. 276 2001 33293 33296
175. K Simons D Toomre Lipid rafts and signal transduction Nat. Rev. Mol. Cell Biol. 1 2000 31 39
176. R.G Sitrin R.F Todd 3rd H.R Petty T.G Brock S.B Shollenberger E Albrecht M.R Gyetko The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of humanmonocytes J. Clin. Invest. 97 1996 1942 1951
177. L Skriver L.I Larsson V Kielberg L.S Nielsen P.B Andresen P Kristensen K Danø Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma J. Cell Biol. 99 1984 752 757
178. E.B Smith W.D Thompson Fibrin as a factor in atherogenesis Thromb. Res. 73 1994 1 19
179. E Soravia A Grebe P De Luca K Helin T.T Suh J.L Degen F Blasi A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene Blood 86 1995 624 635
180. S Sperl U Jacob Arroyo de Prada J Sturzebecher O.G Wilhelm W Bode V Magdolen R Huber L Moroder (4-Aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase Proc. Natl. Acad. Sci. USA 97 2000 5113 5118
181. M.S Stack D.A Johnson Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase) J. Biol. Chem. 269 1994 9416 9419
182. A Stahl B.M Mueller The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae J. Cell Biol. 129 1995 335 344
183. 3 binding to vitronectin Nature 383 1996 441 443
184. C.M Stein N Brown D.E Vaughan C.C Lang A.J Wood Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature J. Am. Coll. Cardiol. 32 1998 117 122
185. R.W Stephens M Aumailley R Timpl T Reisberg H Tapiovaara H Myohanen J Murphy-Ullrich A Vaheri Urokinase binding to laminin-nidogen Structural requirements and interactions with heparin Eur. J. Biochem. 207 1992 937 942
186. R.W Stephens A.M Bokman H.T Myohanen T Reisberg H Tapiovaara N Pedersen J Grøndahl-Hansen M Llinas A Vaheri Heparin binding to the urokinase kringle domain Biochemistry 31 1992 7572 7579
187. R.W Stephens J Pollanen H Tapiovaara K.C Leung P.S Sim E.M Salonen E Rønne N Behrendt K Danø A Vaheri Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants J. Cell Biol. 108 1989 1987 1995
188. M.P Stoppelli A Corti A Soffientini G Cassani F Blasi R.K Assoian Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes Proc. Natl. Acad. Sci. USA 82 1985 4939 4943
189. T Takeuchi J.L Harris W Huang K.W Yan S.R Coughlin C.S Craik Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates J. Biol. Chem. 275 2000 26333 26342
190. T Tarui A.P Mazar D.B Cines Y Takada Urokinase receptor (uPAR/CD87) is a ligand for integrins and mediates cell-cell interaction J. Biol. Chem. 276 2001 3983 3990
191. T Teesalu A Kulla T Asser M Koskiniemi A Vaheri Tissue plasminogen activator as a key effector in neurobiology and neuropathology Biochem. Soc. Trans. 30 2002 183 189
192. S Thorsen M Philips J Selmer I Lecander B Astedt Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2 Eur. J. Biochem. 175 1988 33 39
193. H Tordai L Banyai L Patthy The PAN module: the N-terminal domains of plasminogen and hepatocyte growth factor are homologous with the apple domains of the prekallikrein family and with a novel domain found in numerous nematode proteins FEBS Lett. 461 1999 63 67
194. M.J Towle A Lee E.C Maduakor C.E Schwartz A.J Bridges B.A Littlefield Inhibition of urokinase by 4-substituted benzo [b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor Cancer Res. 53 1993 2553 2559
195. S.E Tsirka T.H Bugge J.L Degen S Strickland Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin Proc. Natl. Acad. Sci. USA 94 1997 9779 9781
196. S.E Tsirka A Gualandris D.G Amaral S Strickland Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator Nature 377 1995 340 344
197. S.E Tsirka A.D Rogove T.H Bugge J.L Degen S Strickland An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus J. Neurosci. 17 1997 543 552
198. R.B Turner L Liu I.Y Sazonova G.L Reed Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin J. Biol. Chem. 277 2002 33068 33074
199. W.E Van Nostrand M Porter Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity Biochemistry 38 1999 11570 11576
200. J.D Vassalli D Belin Amiloride selectively inhibits the urokinase-type plasminogen activator FEBS Lett. 214 1987 187 191
201. J.D Vassalli D Baccino D Belin A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase J. Cell Biol. 100 1985 86 92
202. P Verde M.P Stoppelli P Galeffi P Di Nocera F Blasi Identification and primary sequence of an unspliced human urokinase poly(A) +RNA Proc. Natl. Acad. Sci. USA 81 1984 4727 4731
203. S Verrall N.W Seeds Characterization of 125 I-tissue plasminogen activator binding to cerebellar granule neurons J. Cell Biol. 109 1989 265 271
204. D.J Vines S.W Lee D.A Dichek V Ellis Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase J. Pept. Sci. 6 2000 432 439
205. K.K Wary A Mariotti C Zurzolo F.G Giancotti A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth Cell 94 1998 625 634
206. Y Wei M Lukashev D.I Simon S.C Bodary S Rosenberg M.V Doyle H.A Chapman Regulation of integrin function by the urokinase receptor Science 273 1996 1551 1555
207. Y Wei D.A Waltz N Rao R.J Drummond S Rosenberg H.A Chapman Identification of the urokinase receptor as an adhesion receptor for vitronectin J. Biol. Chem. 269 1994 32380 32388
208. Y Wei X Yang Q Liu J.A Wilkins H.A Chapman A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling J. Cell Biol. 144 1999 1285 1294
209. Z Werb ECM and cell surface proteolysis: Regulating cellular ecology Cell 91 1997 439 442
210. F Werner T.M Razzaq V Ellis Tissue plasminogen activator binds to human vascular smooth muscle cells by a novel mechanism—Evidence for a reciprocal linkage between inhibition of catalytic activity and cellular binding J. Biol. Chem. 274 1999 21555 21561
211. J.M Whitelock A.D Murdoch R.V Iozzo P.A Underwood The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases J. Biol. Chem. 271 1996 10079 10086
212. S.A Wilcox T Reho P.J Higgins E Tominna-Sebald P.J McKeown-Longo Localization of urokinase to focal adhesions by human fibrosarcoma cells synthesizing recombinant vitronectin Biochem. Cell Biol. 74 1996 899 910
213. B Wiman D Collen On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin J. Biol. Chem. 254 1979 9291 9297
214. W Xue A.L Kindzelskii R.F Todd 3rd H.R Petty Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes J. Immunol. 152 1994 4630 4640
215. 5 -directed cell migration J. Biol. Chem. 271 1996 29393 29399
216. L Zhang D Seiffert B.J Fowler G.R Jenkins T.C Thinnes D.J Loskutoff R.J Parmer L.A Miles Plasminogen has a broad extrahepatic distribution Thromb. Haemost. 87 2002 493 501
217. H.M Zhou A Nichols P Meda J.D Vassalli Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis EMBO J. 19 2000 4817 4826